Personalized Quit-Smoking plan: drug or patch tailored to your brain?
NCT ID NCT02162849
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study looks at whether varenicline (a prescription drug) or nicotine patches help people quit smoking more effectively, depending on their natural levels of emotion and attention. About 204 smokers aged 18-75 who smoke at least 5 cigarettes daily will receive behavioral counseling plus one of the treatments. The goal is to see which approach works best for different personality types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOBACCO USE CESSATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Personalized nicotine patch dosing may boost quit rates
- A stronger nicotine patch might break the dual Smoking-Vaping habit
- Could a child's doctor visit spark a parent's quit-smoking journey?
- Quit smoking from your couch: teleconsultation put to the test
- Text message links may boost smoking quit rates — a primary care trial puts the idea to the test
- Text messages as a tool to quit smoking: a trial in kenyan emergency rooms